Schedule 13D ownership disclosure
BRAINSTORM CELL THERAPEUTICS
Security class unavailable · CUSIP: 10501E201
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,035,181
- Percent of class
- 4.5800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001332596-19-000006
- Form type
- SC 13D
- Filer
- BRAINSTORM CELL THERAPEUTICS INC.
- CIK
- CIK 1137883
- Filed
- Nov 21, 2019
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership